Parkinson's disease: Impact of clinical and cognitive aspects on quality of life;Doença de Parkinson: Impacto de aspectos clínicos e cognitivos na qualidade de vida

Dementia e Neuropsychologia

Volumn 4, Issue 2, 2010, Pages 131-137

  Tedrus, Glória Maria Almeida Souza ^a   Fonseca, Lineu Correa ^a   Kange, Patrícia Mencaroni ^a  

^a PONTIFÍCIA UNIVERSIDADE CATÓLICA DE CAMPINAS   (Brazil)

Author keywords

Cognition; Depression; Parkinson's disease; Quality of life

Indexed keywords

EID: 77958103859     PISSN: 19805764     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1980-57642010DN40200010     Document Type: Article

References (39)

1. de Boer AG, Wijker W, Speelman JD, et al. Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 1996;61:70-74.
2. Hobson P, Holden A, Meara J. Measuring the impact of Parkinson's disease with the Parkinson's disease quality of life questionnaire. Age ageing 1999;28:341-346.
3. Karlsen KH, Larsen JP, Tandberg E, Maland JG. Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psiquiatry 1999;66:431-435.
4. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neu-rosurg Psychiatry 2000;69:308-312.
5. Keränen T, Kaakkola S, Sotaniemi K, et al. Economic burden and quality of life impairment increase with severity of PD. Parkinsonism Relat Disord 2003;9:163-168.
6. Barone P, Antoniani A, Colosimo C, et al. The priamo study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson disease. Mov Disord 2009;24:1641-1649.
7. Martinez-Martin P, Arroyo S, Rojo-Albuin JM, Rodriguez- Blazquez C, Frades B, de Pedro Cuesta J. Burden, perceived healthy status, and moon among caregivers of Parkinson's disease patients. Mov Disord 2008;23:1673-1680.
8. Peto V, Jenkinson C, Fitzpatrick R. Determining minimally important differences for the P-39 Parkinson's disease a review of the development, validation and application of a Parkinson disease questionnaire. Age ageing 2001;30:299-302.
9. Peto V, Jenkinson C, Fitzpatrick R. PDQ-39: a review of the development, validation and application of a Parkinson disease quality of life questionnaire and its associated measures. J Neurol 1998;245(Suppl 1):S10-14.
10. Carod-Artal FJ, Martinez-Martin P, Vargas AP. Independent validation of SCOPA-Psychosocial and metric properties of the PDQ-39 Brazilian version. Mov Disord 2007;22:91-98.
11. Lana RC, Alvares LMRS, Nasciutti-Prudente C, Goulart FRP, Teixeira-Salmela LF, Cardoso FE. Percepção da qualidade de vida de indivíduos com doença de Parkinson através do PDQ-39. Rev Bras Fisioter 2007;11:397-402.
12. Souza RG, Borges V, Silva SMCA, Ferraz HB. Quality of life scale in de Parkinson - PDQ-39 (versão do Português falado no Brasil) como instrumento para avaliação de pacientes com e sem futuação motora decorrente da levodopa. Arq Neurop-siquiatr 2007;65:787-791.
13. Scalzo P, Kummer A, Cardoso F, Teixeira AL. Depressive symptoms and perception of quality of life in Parkinson's disease. Arq Neuropsiquiatr 2009;67:203-208.
14. Global Parkinson's disease survey steering committee. Factors impacting quality of life in Parkinson's disease: results from an international survey. Mov Disord 2002;17:60-67.
15. Slawek J, Derejko M, Lass P. Factors affecting the quality of life of patients with idiopathic Parkinson's disease: an cross-section study in an outpatient clinic attendees. Parkinsonism Relat Disod 2005;11:465-468.
16. Kuopio AM, Marttila RJ, Helenius H, et al. The quality of life in Parkinson's disease. Mov Disord 2000;2:216-223.
17. Schrag A. Quality of life and depression in Parkinson's disease. J Neurol Sci 2006;248:151-157.
18. Forsaa EB, Larsen J P, Wentzel-Larsen T, Herlofson K, Alves G. Predictors and course of health-related quality of life in Parkinson's disease. Mov Disord 2008;23:1420-1427.
19. Rabinstein AA, Shulman LM. Management of behavioral and psychiatric problems in Parkinson's disease. Parkinsonism Relat Disord 2000;7:41-50.
20. Klepac N, Trkulja V, Relja M, Babic T. Is quality of life in non-demented Parkinson's disease related to cognitive performance? A clinic-based cross-section study. Eur J Neurol 2008;15:128-133.
21. Calne DB, Snow BJ, Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol 1992;32:S125-S127.
22. Hoehn MM, Yarh MD. Parkinsonism: onset, progression and mortally. Neurology 1967;17:427-442.
23. Goetz CG, Poewe W, Rascol O, et al. Movement Disorder Society Task Force Report on the Hoehn and Yahr Staging Scale: status and recommendations. Mov Disord 2004;19:1020-1028.
24. Morris JC, Heyman A, Mohs RC. The Consortium to establish a registry for Alzheimer's disease (CERAD): part 1. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
25. Bertolucci PHF, Okamoto IH, Brucki SMD, Siviero MO, To-niolo Neto J, Ramos LR. Applicability of the CERAD neuropsychological battery to brazilian elderly. Arq Neuropsiquiatr 2001;59:532-536.
26. Hamilton M. A rating scale for depression. J Neurol Neuro-surg Psychiatr 1960;23:56-62.
27. th Ed. Philadelphia: Lippincott Williams & Wilkins, 2000;1:755-783.
28. Carod-Artal FJ, Vargas AP, Martinez-Martin P. Determinants of quality of life in brazilian patients with Parkinson's disease. Mov Disord 2007;22:1408-1415.
29. Chapuis S, Ouchchane L, Metz O, Gerbaud L, Durif F. Impact of the motor complications of Parkinson disease on quality of life Mov Disord 2005;20: 224-230.
30. Karlsen KH, Tandberg E, Arsland D, Larsen JP. Health related quality of life in Parkinson's disease: a prospective longitudinal study 2000;69:584-589.
31. Lyons KE, Pahwa R, Troester AE. A comparison of Parkinson disease symptoms and self-reported functioning and well being. Parkinsonism Relat Disord 1998;3:207-209.
32. Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poew W, Sampaio C, Tolosa E, Emre M. Diagnostic procedures for Parkinson's disease dementia: recommendations from the Movement Disorder Society Task Force. Mov Disord 2007;22:2314-2324.
33. Miyasaki JM, Shannon K, Voon V, et al. Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson's disease. (an evidence-based review) Neurology 2006;66:996-1002.
34. Verbaan D, Marinus J, Visser M, et al. Cognitive impairment in Parkinson disease. J Neurol Neurosurg Psychiatr 2007;78: 1182-1187.
35. Tedrus GMAS, Fonseca LC, Letro GH, Bossoni AS. Dementia and mild cognitive impairment in Parkinson's disease. Arq Neuropsiquiatr 2009;67:423-427.
36. Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive Profile of patients with newly diagnosed Parkinson's disease. Neurology 2005;65:1239-1245.
37. Uc EY, Rizzo M, Anderson SW, Qian MS, Rodnitzky RL, Dawson JD. Visual dysfunction in Parkinson disease without dementia. Neurology 2005;65:1907-1913.
38. Muslimovic D, Post B, Speelman JD, Scmand B, Haan RJ. Determinants of disability and quality of life in mild to moderate Parkinson's disease. Neurology 2008;70:22419-2247.
39. Bronnick K, Emre M, Lane R, Tekin S, Aarsland D. Profile of cognitive impairment in dementia associates with Parkinson's disease compared with Alzheimer disease. J Neurol Neurosurg Psychiatry 2007;78:1064-1068.